Sydney, Australia

As part of the Global Health Security Conference, GARDP is hosting a pre-conference workshop that focuses on the risks of drug-resistant sexually transmitted infections (STIs) such asNeisseria gonorrhoeaandMycoplasma genitaliumto Australian and regional health security. An expert panel of clinicians and researchers will discuss the spread of drug-resistant STIs, diagnostic and surveillance tools, treatment regimens and guidelines, as well as the potential of new antibiotics and how to address sustainable access.

Event Agenda

1300 –Host: Paul Field, The Global Antibiotic R&D Partnership (GARDP) – Welcome/Introductions
1300 –Dr. Gary Lum, Principal Medical Advisor, Office of Health Protection – TBA
1315 –Prof. Monica Lahra, WHO Collaborating Centre for STI and AMR – Neisseria gonorrhoea AMR: Local, Regional, Global
1330 –Prof. David Whiley, University of Queensland – Detection of Gonococcal Resistance
1345 –Prof. John Kaldor, Kirby Institute, University of New South Wales – Novel strategies for surveillance among populations at higher risk in the region
1400 –Dr. Cassandra Kelly-Cirino, Director, Emerging Threats, FIND – Rapid diagnostic tests for drug-resistant STIs
1415 –Dr. Catriona Bradshaw, Melbourne Sexual Health Centre – Mycoplasma genitalium : Global and regional trends in AMR and management
1430 –Prof. David Lewis, Marie Bashir Institute, University of Sydney – Guidelines and clinical management strategies for NG and MG
1445 –Dr. Seamus O’Brien, R&D Director, GARDP – GARDP’s STIs Program
1500 –Tea
1515-1600 –PANEL DISCUSSION, Chair: David Paterson, Director, UQ centre for clinical research
1600 –Conclusions

Date: Tuesday, 18 June 2019

Venue:ABS Case Study Lecture Theatre 2140, Abercrombie Business School, Corner Abercrombie and Codrington Streets, Darlington, Sydney